In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

Pathologists supported by a new artificial intelligence tool outperformed Standard of Care/Gold standard in determining ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

Panelists discuss how health care providers can optimize quality-of-life and treatment outcomes for patients with ...